查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1923016

半剛性環狀成形術環市場（按材質類型、應用和最終用戶分類）—2026-2032年全球預測

Semi-Rigid Annuloplasty Ring Market by Material Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年半剛性環狀成形術環市值為 3.0502 億美元，預計到 2026 年將成長至 3.2583 億美元，預計到 2032 年將達到 4.9231 億美元，複合年成長率為 7.07%。

關鍵市場統計數據
基準年 2025 3.0502億美元
預計年份：2026年 3.2583億美元
預測年份 2032 4.9231億美元
複合年成長率 (%) 7.07%

半剛性環狀成形術環在現代瓣膜修復中發揮著至關重要的作用，它提供必要的機械支撐和貼合性，在恢復瓣環幾何結構的同時，也能維持瓣葉的動態運動。在二尖瓣和三尖瓣修復中，這些裝置兼顧了結構加固和生理柔軟性，使外科醫生能夠根據退化性、缺血性和功能性疾病狀態來製定修復策略。過去十年，在支持持久療效和保留原生瓣膜解剖結構的證據推動下，臨床醫生越來越傾向於盡可能採用修復方法。因此，兼顧耐用性和血流動力學性能的裝置設計變得日益重要。

從商業性角度來看，產品開發趨勢強調模組化、材料科學以及輸送和植入流程的漸進式創新。製造商正積極回應外科醫生的回饋，設計出能夠簡化尺寸選擇、實現牢固固定並支援微創入路的器械。隨著醫院和心臟中心採用混合手術室模式並投資先進的影像技術，器械的互通性和手術效率正成為重要的差異化因素。因此，對於希望在複雜的醫療環境中加速器材應用並展現其價值的醫療設備團隊、採購經理和臨床領導者而言，了解器材選擇背後的臨床需求、手術流程以及相關人員的獎勵至關重要。

臨床實務、監管路徑和器材創新方面的變革性變化正在改變環狀成形術環修復策略和商業性格局。

半剛性環狀成形術環的市場格局正經歷變革，這主要受臨床、技術和政策因素的共同驅動。微創手術技術和術中影像技術的進步擴大了符合修復條件的患者群體，並改變了瓣膜成形環設計必須應對的手術操作效率。同時，經導管瓣膜治療和混合療法的成熟推動了對能夠與導管介入工作流程整合並能與經皮支撐裝置互補的器械的需求。因此，為了滿足外科醫生的偏好，研發人員優先考慮低輪廓設計、放射性標記以及與內視鏡和機器人平台的兼容性。

2025年美國關稅對心臟植入製造商的設備供應鏈、採購經濟效益與策略採購決策的累積影響

美國於2025年實施並逐步收緊關稅，對半剛性環狀成形術環的製造商和供應商產生了連鎖的營運和戰略影響。關稅帶來的成本壓力迫使採購部門重新評估零件來源和生產地，促使他們採取近岸外包、雙重採購和選擇性供應商整合等策略來降低風險。同時，製造商實施了庫存套期保值，並重新談判了長期供應契約，以穩定投入成本並維持利潤率。這些措施對前置作業時間產生了間接影響，一些公司延長了計劃週期，而其他公司則接受了更高的庫存維修成本，以避免組裝中斷。

對臨床應用、通路、終端用戶畫像和材料選擇進行細分分析，可為推動產品採納、採購和設備設計提供洞察。

細分分析揭示了不同臨床應用、通路、終端用戶環境和材料選擇的需求促進因素和設計優先順序。在應用細分方面，二尖瓣和三尖瓣修復在手術複雜性和臨床終點方面存在差異。二尖瓣修復通常區分初次手術和二次手術，三尖瓣修復也存在類似的初次手術與二次手術之分。這會影響瓣環尺寸選擇演算法、固定策略和術中器械。這些臨床因素既影響設計規範，也影響外科醫師訓練需求，從而形成以植入便利性和術中適應性為決定性因素的細分市場。

影響美洲、歐洲、中東和非洲以及亞太地區醫療保健市場商業化和應用的區域趨勢和臨床基礎設施

區域趨勢塑造著臨床實踐模式、採購標準以及醫療器材開發商必須遵循的法規結構。在美洲，三級心臟中心的手術量集中以及強大的私立醫院體系影響著新產品上市的時機以及外科醫生意見領袖在技術推廣中的作用。同時，北美和拉丁美洲市場的供應鏈網路和報銷模式產生了微妙的需求訊號，開發人員必須解讀這些訊號以調整培訓投入和商業性覆蓋策略。在歐洲、中東和非洲地區，監管協調工作與各國特定的衛生技術評估流程並存，迫使企業採用差異化的證據產生計畫和區域性打入市場策略。

領先的心臟設備開發商的競爭格局和企業策略將如何影響創新、夥伴關係模式和製造地

半剛性環狀成形術環領域的主要企業正採取互補策略，結合有針對性的研發、選擇性併購以及與臨床中心的夥伴關係，以加速實證醫學證據的累積和手術推廣。投資於材料科學和迭代設計改進的企業，透過更低輪廓的器械、更完善的固定系統以及簡化微創植入流程的功能，實現差異化競爭優勢。同時，戰略許可協議和OEM夥伴關係使一些企業能夠在無需承擔地域擴張所需全部資本的情況下，擴大生產規模並拓展配銷通路。

為產業領導者提供切實可行的建議，以調整研發方向、加強供應鏈並改變商業模式，從而適應不斷變化的臨床和政策環境。

行業領導者應優先考慮切實可行的措施，將臨床價值與營運韌性和商業性靈活性相結合。首先，透過重點關注與外科醫生和支付方最相關的手術終點的前瞻性註冊研究和合作主導的研究，推動證據的產生。將真實世界的臨床結果與衛生經濟學見解相結合，將增強合約談判能力，並擴大與支付方的談判平台。其次，實現供應商多元化，確保關鍵零件的替代來源，同時探索近岸外包方案，以降低關稅和地緣政治風險。合約結構應包含數量波動條款和緊急條款，以因應供應中斷。

一套嚴謹的調查方法，說明資料收集、一手和二手檢驗、專家訪談以及檢驗，以確保分析的嚴謹性。

本分析採用混合調查方法，以確保研究結果的平衡性和檢驗。首先，對同行評審的臨床文獻、監管申報文件、醫療設備附加檔進行系統性的二次檢索，以確定半剛性瓣環成形術成形術器械的臨床和技術背景。其次，透過對心臟外科醫生、採購人員、臨床研究人員和監管專家進行結構化訪談，進行一手研究，以收集有關器械性能、推廣障礙和區域採購慣例的經驗性見解。

觀點整合了臨床、商業性和政策方面的見解，為相關人員在創新、夥伴關係和業務永續營運提供指南。

本報告綜合的臨床、商業性和政策證據表明，未來的半剛性環狀成形術環必須滿足嚴格的動態標準，同時適應不斷變化的輸送途徑。在臨床上，隨著修復策略擴展到更多患者群體，能夠簡化植入過程並兼顧瓣膜動力學的器械設計仍然至關重要。在商業性，那些將臨床結果與可證明的經濟價值掛鉤、投資於臨床醫生教育並採用反映當地採購實踐的靈活分銷和定價模式的公司將獲得成功。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 半剛性環狀成形術環市場（依材料類型分類）

  • 鈷鉻
  • 聚合物
  • 鈦

第9章 半剛性環狀成形術環市場：依應用分類

  • 二尖瓣修復
    • 主要介入措施
    • 二級干預
  • 三尖瓣修復
    • 主要介入措施
    • 二級干預

10. 按最終用戶分類的半剛性環狀成形術環市場

  • 門診手術中心
  • 心臟診所
    • 綜合診所
    • 獨立心臟診所
  • 醫院
    • 私立醫院
    • 公立醫院

11. 各地區半剛性環狀成形術環市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

12. 半剛性環狀成形術環市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

13. 各國半剛性環狀成形術環市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 美國半剛性環環狀成形術環市場

第15章 中國半剛性環狀成形術環市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 4C Medical Technologies, Inc.
  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Boston Scientific Corporation
  • CardioMech AS
  • Cardiosolutions, Inc.
  • Coramaze Technologies GmbH
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • JenaValve Technology, Inc.
  • LivaNova PLC
  • Magenta Medical Ltd.
  • Medtronic plc
  • Medtronic, Inc.
  • Micro Interventional Devices, Inc.
  • Mitralign, Inc.
  • MValve Technologies Ltd.
  • Neovasc Inc.
  • Peijia Medical Limited
  • Suzhou Jiecheng Medical Co., Ltd.
  • Tendyne Holdings, Inc.
  • Xeltis AG
Product Code: MRR-867BED9A9EC7

The Semi-Rigid Annuloplasty Ring Market was valued at USD 305.02 million in 2025 and is projected to grow to USD 325.83 million in 2026, with a CAGR of 7.07%, reaching USD 492.31 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 305.02 million
Estimated Year [2026] USD 325.83 million
Forecast Year [2032] USD 492.31 million
CAGR (%) 7.07%

Semi-rigid annuloplasty rings occupy a critical role in contemporary valvular repair by providing the mechanical support and conformability required to restore annular geometry while preserving dynamic leaflet motion. During mitral and tricuspid valve repairs, these devices balance structural reinforcement with physiological flexibility, enabling surgeons to tailor repair strategies across degenerative, ischemic, and functional disease states. Over the past decade, clinicians have increasingly preferred repair approaches where feasible, driven by evidence favoring durable outcomes and preservation of native valve anatomy, which in turn places a premium on device design that harmonizes durability with hemodynamic performance.

From a commercial perspective, product development trends emphasize modularity, material science, and incremental innovations in delivery and implantation workflow. Manufacturers are responding to surgeon feedback with designs that simplify sizing and secure fixation while enabling minimally invasive access routes. As hospitals and cardiac centers adopt hybrid operating room models and invest in advanced imaging, device interoperability and procedural efficiency have emerged as differentiators. Consequently, understanding the clinical imperatives, procedural workflows, and stakeholder incentives that underpin device selection is essential for medical device teams, purchasing leaders, and clinical champions aiming to accelerate adoption and demonstrate value in complex care environments.

Transformative shifts in clinical practice, regulatory pathways, and device innovation that are changing repair strategies and the commercial outlook for annuloplasty rings

The landscape for semi-rigid annuloplasty rings is undergoing transformative shifts driven by converging clinical, technological, and policy forces. Minimally invasive surgical techniques and enhanced intraoperative imaging have expanded the candidate pool for repair procedures and changed the procedural ergonomics that ring designs must accommodate. Simultaneously, the maturation of transcatheter valve therapies and hybrid approaches has increased demand for devices that integrate with catheter-compatible workflows or complement percutaneous adjuncts. As a result, developers are prioritizing low-profile geometries, radiopaque markers, and compatibility with endoscopic and robotic platforms to align with evolving surgeon preferences.

Regulatory and reimbursement dynamics are also evolving, with authorities emphasizing real-world evidence, post-market surveillance, and value demonstration. Payers increasingly expect robust clinical and economic justification for device selection, which elevates the importance of prospective registries and health economics studies. Moreover, supply chain resilience and a shift toward strategic partnerships, including co-development and licensing arrangements, are reshaping how firms bring incremental innovations to market. Taken together, these shifts are redefining both clinical adoption curves and commercial strategies, making agility and evidence generation central to long-term competitiveness.

Cumulative effects of United States tariffs in 2025 on device supply chains, procurement economics, and strategic sourcing decisions for cardiac implant makers

The introduction and escalation of United States tariffs in 2025 created a cascade of operational and strategic impacts for manufacturers and suppliers involved in semi-rigid annuloplasty ring production. Tariff-driven cost pressures pushed procurement teams to re-evaluate component sourcing and origin-of-manufacture choices, incentivizing a mix of nearshoring, dual sourcing, and selective supplier consolidation to mitigate exposure. In parallel, manufacturers implemented inventory hedging and renegotiated long-term supply contracts to stabilize input costs and preserve margin integrity. These measures had second-order effects on lead times, with some organizations extending planning horizons and others accepting higher carrying costs to avoid assembly interruptions.

Beyond operational adjustments, tariffs influenced product roadmaps by prompting material substitution studies and design optimizations that reduce component complexity without sacrificing clinical performance. Regulatory teams confronted altered supplier landscapes and supply chain documentation requirements, increasing the emphasis on supplier qualification and traceability. Commercial teams faced pressure to articulate the value proposition of premium device features more clearly to justify any incremental price adjustments. Collectively, these dynamics accelerated strategic realignments across procurement, product development, and commercial operations, underscoring the need for scenario planning and adaptive contracting strategies.

Segmentation insights across clinical use, distribution routes, end-user profiles, and material selection that drive adoption, procurement, and device design

Segmentation analysis reveals distinct demand drivers and design priorities across clinical applications, distribution pathways, end-user environments, and material choices. Within application segmentation, mitral valve repair and tricuspid valve repair present different procedural complexities and clinical endpoints; mitral valve repair commonly differentiates between primary intervention and secondary intervention settings, and the same primary versus secondary distinction applies to tricuspid valve repair, which influences ring sizing algorithms, fixation strategies, and intraoperative instrumentation. These clinical layers affect both design specifications and surgeon training requirements, creating subsegments where ease of implantation or intraoperative adaptability becomes a decisive factor.

Distribution segmentation exposes the contrast between corporate direct sales and OEM direct sales under the direct sales umbrella, and between national distributors and regional distributors within distributor networks. Direct corporate and OEM channels enable tighter control over clinical education and pricing, whereas national and regional distributors offer broader geographic reach and local account management. End-user segmentation spans ambulatory surgical centers, cardiac clinics, and hospitals, and within clinics the split between multispecialty clinics and standalone cardiac clinics matters for procedural volume and device purchasing cycles; hospitals also vary between private and public institutions, each with different procurement protocols and capital approval processes. Material type segmentation-Cobalt-Chromium, Polymer, and Titanium-further layers product differentiation, with each material presenting trade-offs in stiffness, fatigue resistance, radiopacity, and cost that steer clinical preference and manufacturing choices. Integrating these segmentation dimensions helps firms target clinical claims, refine go-to-market strategies, and prioritize development efforts that align with distinct customer economics and procedural settings.

Regional dynamics and clinical infrastructure that influence commercialization and adoption across the Americas, EMEA, and Asia-Pacific healthcare markets

Regional dynamics shape clinical practice patterns, procurement norms, and the regulatory frameworks that device developers must navigate. In the Americas, procedural volume concentrations in tertiary cardiac centers and a strong private hospital sector influence adoption timing and the role of surgeon opinion leaders in technology diffusion. Meanwhile, supply chain networks and reimbursement models in North and Latin American markets create nuanced demand signals that developers must interpret to align training investments and commercial coverage strategies. Across Europe, Middle East & Africa, regulatory harmonization efforts coexist with country-specific health technology assessment processes, prompting firms to adopt differentiated evidence generation plans and localized market entry tactics.

In the Asia-Pacific region, the heterogeneity of healthcare infrastructure-from advanced university hospitals to rapidly expanding private systems-drives a bifurcated approach to commercialization that balances premium product positioning with cost-effective design options. Across all regions, investment in clinician education, registry participation, and local partnerships accelerates adoption. Moreover, regional capacity for minimally invasive and hybrid procedures, the pace of infrastructure modernization, and public policy priorities regarding domestic manufacturing and procurement all influence where and how manufacturers allocate R&D, manufacturing footprints, and commercial resources.

Competitive landscape and corporate strategies shaping innovation, partnership models, and manufacturing footprints of leading cardiac device developers

Leading companies in the semi-rigid annuloplasty ring domain are deploying complementary strategies that combine targeted R&D, selective M&A, and collaborative partnerships with clinical centers to accelerate evidence generation and surgical adoption. Firms investing in material science and iterative design improvements are increasingly differentiating through lower-profile devices, enhanced fixation systems, and features that streamline minimally invasive implantation. At the same time, strategic licensing agreements and OEM partnerships help some players scale manufacturing and extend distribution reach without incurring the full capital requirements of geographic expansion.

Competitive positioning also hinges on service and support capabilities: companies demonstrating comprehensive surgeon training programs, simulator-based education, and robust post-market surveillance arrangements tend to build stronger trust with high-volume centers and key opinion leaders. Manufacturing strategies differ as well, with some organizations prioritizing in-house precision metallurgy and others relying on contract manufacturers to optimize cost and capacity. Across the competitive set, success increasingly depends on the ability to link clinical outcomes to economic arguments, to sustain regulatory compliance across jurisdictions, and to adapt commercial models that reflect regional procurement practices and institutional purchasing cycles.

Actionable recommendations to help industry leaders align R&D, strengthen supply chains, and adapt commercial models to changing clinical and policy realities

Industry leaders should prioritize a set of pragmatic, actionable measures that align clinical value with operational resilience and commercial agility. First, advance evidence generation through focused prospective registries and collaborative investigator-led studies that address procedural endpoints most relevant to surgeons and payers; linking real-world outcomes to health economics narratives will strengthen contracting positions and payer negotiations. Second, diversify supplier bases and qualify alternative sources for critical components while exploring nearshoring options to reduce tariff and geopolitical exposure; contract structures should include volume-flex and contingency clauses to mitigate supply interruptions.

Third, optimize product portfolios by aligning material choices and device profiles with regional procedural mix and procurement sensitivities, ensuring that premium features are paired with clear clinical advantages. Fourth, invest in modular training programs and digital education platforms to accelerate surgeon proficiency in minimally invasive and hybrid approaches. Finally, adopt flexible commercial models-ranging from capital leasing to outcome-based arrangements-where appropriate, to lower adoption barriers and demonstrate shared risk with institutional customers. These steps collectively foster a resilient, evidence-led approach to growth and adoption in complex clinical environments.

Robust research methodology describing data collection, primary and secondary validation, expert interviews, and triangulation that ensure analytical rigor

This analysis integrates a mixed-method research methodology to ensure balanced, verifiable insights. The foundation includes systematic secondary research across peer-reviewed clinical literature, regulatory filings, device labeling, and procedural guidance documents, which established the clinical and technological context for semi-rigid annuloplasty devices. Complementing this, primary research comprised structured interviews with cardiac surgeons, procurement leaders, clinical researchers, and regulatory specialists to capture experiential perspectives on device performance, adoption barriers, and regional procurement practices.

Data synthesis relied on triangulation across sources, with iterative validation workshops involving clinician advisors and industry experts to reconcile divergent viewpoints and confirm practical relevance. The methodology emphasized transparency in source attribution, explicit documentation of assumptions, and sensitivity testing for alternative supply chain and reimbursement scenarios. Limitations include variability in reporting across institutions and evolving policy actions that may alter the strategic landscape; accordingly, conclusions prioritize robust, qualitative insights and recommended actions over speculative quantitative forecasts.

Concluding perspective synthesizing clinical, commercial, and policy insights to guide stakeholders on innovation, partnerships, and operational resilience

The combined clinical, commercial, and policy evidence synthesized in this report points to a future where semi-rigid annuloplasty rings must simultaneously satisfy demanding biomechanical criteria and adapt to shifting adoption pathways. Clinically, device designs that respect annular dynamics while enabling simplified implantation will maintain relevance as repair strategies are extended across patient populations. Commercially, success will favor firms that link clinical outcomes to demonstrable economic value, invest in clinician education, and deploy flexible distribution and pricing models that reflect regional procurement realities.

Operational resilience and a proactive approach to regulatory evidence generation will remain critical as tariff regimes, supplier footprints, and reimbursement frameworks continue to evolve. For stakeholders-manufacturers, hospital procurement teams, clinical leaders, and investors-the imperative is to combine rigorous clinical validation with adaptive commercial strategies and fortified supply chain planning to preserve continuity of care and sustain innovation momentum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Semi-Rigid Annuloplasty Ring Market, by Material Type

  • 8.1. Cobalt-Chromium
  • 8.2. Polymer
  • 8.3. Titanium

9. Semi-Rigid Annuloplasty Ring Market, by Application

  • 9.1. Mitral Valve Repair
    • 9.1.1. Primary Intervention
    • 9.1.2. Secondary Intervention
  • 9.2. Tricuspid Valve Repair
    • 9.2.1. Primary Intervention
    • 9.2.2. Secondary Intervention

10. Semi-Rigid Annuloplasty Ring Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Clinics
    • 10.2.1. Multispecialty Clinics
    • 10.2.2. Standalone Cardiac Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Semi-Rigid Annuloplasty Ring Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Semi-Rigid Annuloplasty Ring Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Semi-Rigid Annuloplasty Ring Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Semi-Rigid Annuloplasty Ring Market

15. China Semi-Rigid Annuloplasty Ring Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. 4C Medical Technologies, Inc.
  • 16.6. Abbott Laboratories
  • 16.7. Anteris Technologies Ltd.
  • 16.8. Boston Scientific Corporation
  • 16.9. CardioMech AS
  • 16.10. Cardiosolutions, Inc.
  • 16.11. Coramaze Technologies GmbH
  • 16.12. CryoLife, Inc.
  • 16.13. Edwards Lifesciences Corporation
  • 16.14. JenaValve Technology, Inc.
  • 16.15. LivaNova PLC
  • 16.16. Magenta Medical Ltd.
  • 16.17. Medtronic plc
  • 16.18. Medtronic, Inc.
  • 16.19. Micro Interventional Devices, Inc.
  • 16.20. Mitralign, Inc.
  • 16.21. MValve Technologies Ltd.
  • 16.22. Neovasc Inc.
  • 16.23. Peijia Medical Limited
  • 16.24. Suzhou Jiecheng Medical Co., Ltd.
  • 16.25. Tendyne Holdings, Inc.
  • 16.26. Xeltis AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COBALT-CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COBALT-CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COBALT-CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIMARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SECONDARY INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MULTISPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MULTISPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY STANDALONE CARDIAC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY STANDALONE CARDIAC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY STANDALONE CARDIAC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 131. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 135. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 136. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 138. GCC SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 155. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 159. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 160. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 162. G7 SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 167. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 168. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 170. NATO SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY MITRAL VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY TRICUSPID VALVE REPAIR, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY CARDIAC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA SEMI-RIGID ANNULOPLASTY RING MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)